April 24, 2026
|9 min read
Why Animal Health R&D Teams Resist Digital Tools: Three Patterns from the Teams That Broke Through
TL;DR
Prelude works with 8 of the top 10 animal health pharma companies and all three top pet nutrition brands. Across those engagements, the same three resistance patterns appear in almost every adoption: the “my study is different” defense, the perpetual proof-of-concept trap, and the generational bifurcation. Technology rarely blocks adoption in animal health R&D. These three patterns do. Here’s how to recognize each, and what the teams that broke through actually did differently.
Most stories about digital transformation blame the technology. In animal health R&D, technology is almost always the easy part. The hard part is human.
Prelude has powered animal health research for over 20 years, working with nearly every major animal health company in the US and Europe across more than 250 sites. In that time, we’ve watched clinical, preclinical, and nutrition research teams move from paper-based studies to digital evidence collection. The ones that succeeded had almost nothing in common technically. The ones that stalled shared the same three resistance patterns.
None of these patterns show up cleanly in the standard change management literature, because most of that literature is built on human pharma or generic enterprise IT. Animal health R&D runs on different regulatory frameworks, smaller teams covering broader scope, field studies in remote conditions, and multi-species portfolios. The resistance patterns are different too.
Pattern 1: The “My Study Is Different” Defense
Every investigator can produce a reason their work is the exception. Livestock studies are different because of group-level data. Aquaculture is different because of environmental variability. Companion animal efficacy is different because of owner compliance. Preclinical is different because of the animal room reality.
They are all correct. That is what makes this pattern so hard to break.
A livestock research lead described the resistance this way in a recent conversation:
“Some of our CROs say this is the way we do it, we do it well, it’s a process. We have it down.”
The specific objections change. The underlying logic is always the same: my situation is too specialized for a general digital workflow.
The teams that break through do not debate exceptions. They pick the hardest exception, usually livestock group-level data or offline field data collection in barns without connectivity, and they design the digital workflow for that case specifically. Once the most complex workflow is running, the “my study is different” defense loses its grip on every other study type.
What we’ve seen work: Start with the hardest study type, not the easiest.
Pattern 2: The Perpetual Proof-of-Concept Trap
A researcher evaluating the platform asked us to map out every conceivable scenario before agreeing to pilot anything.
“How does it handle group entry? What about offline? What if animals come through in random order? What if we need to change the protocol mid-study?”
This looks like technical due diligence. It is something deeper. It is a psychological requirement for certainty before commitment. The animal health R&D culture reinforces it, because surprises in a regulated study are not just inconvenient. They have career consequences.
The teams that get stuck treat evaluation as permanent. Another demo, another scenario walkthrough, another proof point. Time passes. Nothing gets piloted.
The teams that break through commit to a narrow first study, run it end-to-end on the new system, and accept that the first study will expose questions nobody anticipated. They budget for that explicitly. In practice, the first live study generates more useful learning than extensive pre-purchase evaluation ever could.
What we’ve seen work: Replace “evaluate everything first” with “commit to one study, learn from it, expand.”
Pattern 3: The Generational Bifurcation
As one industry veteran put it:
“This is the way we do it, we do it well, it’s a process. We have it down. Then you have younger people coming up who are used to more technology.”
Two camps end up pulling in opposite directions, and leadership often does not see the split until the adoption effort has already stalled.
This is not a tooling problem. It is a recognition problem.
Veteran investigators have decades of proven competency in paper-based workflows. A digital system does not just change their tools. It questions the value of their expertise. That is identity, not preference, and identity-level resistance does not respond to training. As a livestock R&D leader at one of our partner organizations told us:
“If you can build confidence with stubborn people like me, you’ve got it made.”
The self-awareness is the opening.
The teams that break through do not try to convert veterans through training. They pair veterans with roles inside the digital workflow that make decades of judgment more valuable, not less: protocol design review, data integrity sign-off, cross-study pattern analysis. Work that is only possible because data is structured. When the veteran sees that the digital system makes their judgment more consequential rather than less, resistance tends to collapse.
What we’ve seen work: Give veterans the parts of the workflow that only make sense with structured data. Don’t ask them to adopt. Ask them to supervise.
What Actually Moves Teams from Resistance to Adoption
Across the animal health R&D transformations we’ve seen succeed, three practices consistently appear. None are novel change management concepts. What’s novel is how they apply specifically in this field.
Participatory design, scoped narrowly. The teams that stall try to co-design everything. The teams that succeed pick a small number of high-friction workflow moments (group-level vaccination entry, exception-flagging during daily observation, multi-site protocol amendment propagation) and co-design only those. Everything else gets the default workflow. The scope discipline is the real differentiator, not the participatory framing.
Peer champions who earn the role. The most effective champions we’ve seen in every deployment started as skeptics. They were not selected for enthusiasm. They converted once they saw a specific result that mattered to them personally. In one aquaculture team, the tipping point was the moment a researcher realized a three-step manual process (calculate in Excel, transcribe, enter into analysis) collapsed into one. She became an advocate because she had a story to tell. Assigned champions don’t have stories. Converted skeptics do.
Transparent communication about trade-offs, not just benefits. Every R&D team has heard the benefits pitch before. What actually builds trust is naming the trade-offs honestly. The early workflow will feel slower. Veterans will feel de-skilled before they see their new value. Site coordinators will push back on data entry that looks redundant until the audit trail logic gets explained. Leaders who name trade-offs out loud get adoption. Leaders who sell only benefits get resentment.
What This Means for Leaders
Most stalled transformations in animal health R&D are not failing in a dramatic way. They are running two systems in parallel indefinitely because nobody addressed the three resistance patterns above. That is worse than failing. It is failure with permanent carrying cost.
If you are evaluating digital evidence infrastructure for your organization, the technology question is the second-order question. The first-order question is whether your team can navigate the three patterns above, and whether your vendor has seen this playbook before or is learning it with you.
FAQs
In our context, change management means systematically helping clinical, preclinical, nutrition, and feed research teams move from paper-based or ad-hoc workflows to a validated digital evidence platform, while addressing the psychological patterns that stall most transitions.
Because the benefits accrue to the organization and the costs accrue to the individual. Investigators bear the learning curve, the temporary productivity loss, and the perceived devaluation of their paper-era expertise. Until the personal costs are addressed, the organizational benefits do not resolve the resistance.
Through participatory workflow design scoped narrowly to high-friction moments, peer champions who convert from skeptics rather than being assigned, and transparent communication about trade-offs (not just benefits). These three practices consistently outperform top-down mandates and training-first rollouts.
Leadership willingness to name trade-offs honestly. The teams that sold only benefits and hid the costs tend to stall. The teams that explain the early period will be harder and that veteran roles will shift before the advocates emerge tend to succeed. The counterintuitive rule: telling the truth about the cost of change is what accelerates adoption.
Almost never from training programs. Champions emerge when a specific skeptical team member experiences a specific concrete result. The leadership job is not to recruit champions. It is to engineer early, specific wins and let the champions name themselves.
Get the Weekly Briefing for Animal Health R&D Leaders
Prelude has powered animal health research for over 20 years. We work with 8 of the top 10 animal health pharma companies and all three top pet nutrition brands, across clinical, preclinical, post-market, and feed and nutrition studies.
Subscribe to AH Weekly for the patterns, decisions, and regulatory shifts shaping how animal health evidence is generated and defended. Short, specific, actionable reading for people who lead R&D in this field.
Related Resources
- Making the Switch: From Paper to EDC
- Prelude EDC Modules for Animal Health
- How to Review Data in an EDC
- Animal Health Clinical Trials at Prelude
Sources
- CAS. (2023). Digital transformation in the pharma industry.
- Yue, C.A., Men, L.R., & Ferguson, M.A. (2019). Bridging transformational leadership, transparent communication, and employee openness to change: The mediating role of trust.
- Smollan, R.K. (2022). Employee coping with organizational change. National Library of Medicine (PMC).
- Vation Ventures. (2025). Change management guide: enabling real adoption and long-term value of technology initiatives.
Subscribe to our newsletter and stay up to date on the latest.
Sign up for our newsletter
